The KIT-d-MMAE group demonstrated a substantial reduction in tumor weight, about 56% tumor inhibition rate (p = 0.0071) compared to the DPBS group (Figure 8D), along with significantly lower Ki67 levels (Figure 8F). This evidence concerns the gene MKI67 and neoplasm.